<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02980887</url>
  </required_header>
  <id_info>
    <org_study_id>16-860</org_study_id>
    <nct_id>NCT02980887</nct_id>
  </id_info>
  <brief_title>Pulmonary Vascular Disease Phenomics Program PVDOMICS</brief_title>
  <acronym>PVDOMICS</acronym>
  <official_title>Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics (PVDOMICS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is recognized that patients with various forms of heart and lung disease exhibit varying
      degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular
      dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not
      well understood. Rapid advances in high throughput omic methodology, combined with powerful
      bioinformatics and network biology capability, have created the opportunity to conduct
      studies that broadly search for homologies and differences across the spectrum of disease
      states associated with pulmonary hypertension, and determinants of the spectrum of right
      ventricular compensation that accompanies these conditions
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protocol is designed to lead to new understanding of patients with pulmonary hypertension
      and right heart dysfunction, based on molecular, clinical, hemodynamic and radiographic
      characteristics. New classifications will be a product of association of these in depth
      phenotypic descriptions with specific molecular mechanisms of pathogenesis. The protocol will
      be implemented to lead to identification of both sub-phenotypes of lung vascular disease and
      to biomarkers of disease that may be useful for early diagnosis or for assessment of
      interventions to prevent or treat this condition.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Precision based definitions of pulmonary vascular diseases (PVD)</measure>
    <time_frame>Over 5 years</time_frame>
    <description>OMICs analyses will be used to assign new class of PVD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of biomarkers for PVD</measure>
    <time_frame>5 years</time_frame>
    <description>OMICs and other measures of disease</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Healthy controls No intervention as this is an observational study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary Vascular Disease</arm_group_label>
    <description>Pulmonary Vascular Disease at risk for pulmonary hypertension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary Hypertension</arm_group_label>
    <description>Those meeting WHO group classifications 1-5 of pulmonary hypertension</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>There is no intervention in this observational study</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Pulmonary Vascular Disease</arm_group_label>
    <arm_group_label>Pulmonary Hypertension</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples for Omics analyses, including DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with pulmonary hypertension, Pulmonary hypertension vascular, and healthy controls
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients ages &gt;18 years of age referred for right heart catheterization for further
        evaluation of known PVD or to be at risk for PVD due to established cardiac disease or
        pulmonary disease

          -  Able to perform complete diagnostic testing listed subsequently (cardiac
             catheterization, echo, exercise test, PFT's, ECG, chest CT, quality of life
             questionnaires, ventilation/perfusion scan, cardiac MRI, body composition
             bioimpedance, and sleep study)

          -  Subject signs informed consent to perform required testing for the protocol

        Exclusion Criteria:

        Dialysis dependent renal function; In the clinician's opinion, too ill to perform the
        protocol testing; Pregnant or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas S Hill, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tufts University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lei Xiao, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Heart, Lung, and Blood Institute (NHLBI)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serpil C Erzurum, MD</last_name>
    <phone>216-445-6624</phone>
    <email>erzurus@ccf.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerald J Beck, PhD</last_name>
    <phone>216-444-9927</phone>
    <email>beckg@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arizona Health Sciences Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franz Rischard, MD</last_name>
      <phone>520-626-6380</phone>
      <email>frischard@deptofmed.arizona.edu</email>
    </contact>
    <contact_backup>
      <last_name>Heidi Erickson, RN</last_name>
      <phone>520-626-5287</phone>
      <email>herickso@email.arizona.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Hassoun, MD</last_name>
      <phone>410-614-5158</phone>
      <email>phassoun@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Blessing Enobun</last_name>
      <phone>410-502-4362</phone>
      <email>benobun1@jhu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Leopold, MD</last_name>
      <phone>617-525-4846</phone>
      <email>jleopold@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>Laurie Lawler, RN</last_name>
      <phone>617-525-9731</phone>
      <email>llawler@bwh.harvard.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Frantz, MD</last_name>
      <phone>507-284-4072</phone>
      <email>frantz.robert@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kristal Rohwer</last_name>
      <phone>507-255-8923</phone>
      <email>rohwer.kristal@mayo.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Columbia University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Berman-Rosenzweig, MD</last_name>
      <phone>212-305-4436</phone>
      <email>esb14@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Aisha Banks, CRC</last_name>
      <phone>212-342-1456</phone>
      <email>ab3696@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Horn, MD</last_name>
      <phone>212-746-2381</phone>
      <email>horneve@med.cornell.edu</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Ricketts, MS</last_name>
      <phone>212-746 - 2698</phone>
      <email>mdr2001@med.cornell.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Hemnes, MD</last_name>
      <phone>615-343-8227</phone>
      <email>anna.r.hemnes@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Errine Garnett, BS</last_name>
      <phone>615-343-4252</phone>
      <email>errine.t.garnett@vanderbilt.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://qhsapps.ccf.org/pvd/</url>
    <description>PVDOMICS study website</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2016</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary arterial hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

